162 related articles for article (PubMed ID: 16982331)
1. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
Uesato N; Fukui K; Maruhashi J; Tojo A; Tajima N
Exp Hematol; 2006 Oct; 34(10):1385-92. PubMed ID: 16982331
[TBL] [Abstract][Full Text] [Related]
2. JTE-607, a multiple cytokine production inhibitor, induces apoptosis accompanied by an increase in p21waf1/cip1 in acute myelogenous leukemia cells.
Tajima N; Fukui K; Uesato N; Maruhashi J; Yoshida T; Watanabe Y; Tojo A
Cancer Sci; 2010 Mar; 101(3):774-81. PubMed ID: 20028380
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of glucocorticoids, cyclosporine A, and JTE-607 [(-)-Ethyl-N[3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzoyl]-L-phenylalaninate dihydrochloride] in a mouse septic shock model.
Iwamura H; Sato M; Wakitani K
J Pharmacol Exp Ther; 2004 Dec; 311(3):1256-63. PubMed ID: 15280441
[TBL] [Abstract][Full Text] [Related]
4. The topoisomerase I inhibitor DX-8951f is active in a severe combined immunodeficient mouse model of human acute myelogenous leukemia.
Vey N; Giles FJ; Kantarjian H; Smith TL; Beran M; Jeha S
Clin Cancer Res; 2000 Feb; 6(2):731-6. PubMed ID: 10690560
[TBL] [Abstract][Full Text] [Related]
5. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
[TBL] [Abstract][Full Text] [Related]
6. Direct inhibition of human acute myeloid leukemia cell growth by IL-12.
Ferretti E; Di Carlo E; Cocco C; Ribatti D; Sorrentino C; Ognio E; Montagna D; Pistoia V; Airoldi I
Immunol Lett; 2010 Oct; 133(2):99-105. PubMed ID: 20705102
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.
Zorzoli A; Di Carlo E; Cocco C; Ognio E; Ribatti D; Ferretti E; Dufour C; Locatelli F; Montagna D; Airoldi I
Clin Cancer Res; 2012 Mar; 18(6):1630-40. PubMed ID: 22383738
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study of 131I-labeled granulocyte macrophage colony-stimulating factor in SCID mouse-acute myeloid leukemia model].
Deng YJ; Lou SF; Xu YZ
Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):33-6. PubMed ID: 17649724
[TBL] [Abstract][Full Text] [Related]
9. Effects of a cytokine inhibitor, JTE-607, on the response to endotoxin in healthy human volunteers.
Borozdenkova S; Mant TG; Allen E; Pu K; Hoshino S; Jurcevic S
Int Immunopharmacol; 2011 Nov; 11(11):1837-43. PubMed ID: 21820084
[TBL] [Abstract][Full Text] [Related]
10. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice.
Beran M; Pisa P; Kantarjian H; Porwit A; Bjorkholm M
Hematol Pathol; 1994; 8(4):135-54. PubMed ID: 7860433
[TBL] [Abstract][Full Text] [Related]
11. In vivo therapeutic effects of IFN-gamma on human myelogenous leukemia in a severe combined immunodeficiency mouse model.
Arai C; Tsuzaki Y; Nagano Y
In Vivo; 1999; 13(6):445-51. PubMed ID: 10757035
[TBL] [Abstract][Full Text] [Related]
12. Conditions for engraftment of human acute myeloid leukemia (AML) in SCID mice.
Terpstra W; Prins A; Visser T; Wognum B; Wagemaker G; Löwenberg B; Wielenga J
Leukemia; 1995 Sep; 9(9):1573-7. PubMed ID: 7658726
[TBL] [Abstract][Full Text] [Related]
13. Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival.
Monaco G; Konopleva M; Munsell M; Leysath C; Wang RY; Jackson CE; Korbling M; Estey E; Belmont J; Andreeff M
Stem Cells; 2004; 22(2):188-201. PubMed ID: 14990858
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
[TBL] [Abstract][Full Text] [Related]
15. JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice.
Kakutani M; Takeuchi K; Waga I; Iwamura H; Wakitani K
Inflamm Res; 1999 Aug; 48(8):461-8. PubMed ID: 10493164
[TBL] [Abstract][Full Text] [Related]
16. Establishment of an in vivo human myeloid leukemia model in the SCID mouse.
Arai C; Tsuzaki Y; Arai N; Takeuchi M; Kurimoto M; Nagano Y
In Vivo; 1999; 13(1):35-40. PubMed ID: 10218130
[TBL] [Abstract][Full Text] [Related]
17. [Biodistribution study of 131I-gM-CSF in SCID mice bearing human leukemia].
Xu YZ; Lou SF; Deng YJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):678-81. PubMed ID: 17343200
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling.
Shen J; Tai YC; Zhou J; Stephen Wong CH; Cheang PT; Fred Wong WS; Xie Z; Khan M; Han JH; Chen CS
Exp Hematol; 2007 Jan; 35(1):75-83. PubMed ID: 17198876
[TBL] [Abstract][Full Text] [Related]
19. JTE-607, an inflammatory cytokine synthesis inhibitor, attenuates ischemia/reperfusion-induced renal injury by reducing neutrophil activation in rats.
Asaga T; Ueki M; Chujo K; Taie S
J Biosci Bioeng; 2008 Jul; 106(1):22-6. PubMed ID: 18691526
[TBL] [Abstract][Full Text] [Related]
20. CDA-II, a urinary preparation, induces growth arrest and apoptosis of human leukemia cells through inactivation of nuclear factor-kappaB in a caspase-dependent manner.
Huang J; Yang M; Liu H; Jin J
Food Chem Toxicol; 2009 Jan; 47(1):40-9. PubMed ID: 18761050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
